When NIH terminated a grant for Northwestern's Minoli Perera to study responses to clopidogrel, a blood thinner, in Puerto Ricans, $250,000 "might as well have been flushed down the toilet, because you built all of this to do nothing with it,” she told me. “I find it just sickening to think about.”
